Privia Lifts 2026 Guidance After $374M Medicare Shared Savings Haul
PRVA sits 34% above its 52-week low of $18.915.
Summary
Privia's ten ACOs generated $374.0 million in shared savings for the 2025 Medicare Shared Savings Program performance year, up 59.7% from 2024, with a 38.1% increase excluding the Evolent Care Partners ACO acquired in December 2025. The ACOs managed over $4.0 billion in benchmark spend across more than 4,700 providers and 297,000 Medicare beneficiaries, and delivered an aggregate savings rate of 9.3% (11.2% excluding the acquired ACO). Management raised full-year 2026 guidance: revenue to $2,550-2,600 million from $2,500-2,550 million, Care Margin to $565-570 million from $535-540 million, Platform Contribution to $305-310 million from $280-285 million, and Adjusted EBITDA to $174-177 million from $154-157 million — roughly 39.8% EBITDA growth at the midpoint versus 2025. This comes two weeks after Q3 results (revenue $657.0M, +13.2%) and the $36 million American Choice Healthcare MSSP acquisition, and the company now expects at least $550 million in cash at year end including that outlay. The guidance raise is the actionable piece: it lifts the EBITDA midpoint by about $20 million, a meaningful step for a company of this size, and confirms the MSSP economics are scaling rather than one-off. Q4 and full-year 2026 results are due in late February 2027.
At the time of this announcement, PRVA was trading at $25.26 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $3.2B. The 52-week trading range was $18.92 to $28.82. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: GlobeNewswire.